Drugs / LP-51
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06706050 | May → Jun 2023 | — | Ho-Yeon Song | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LP-51 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06706050 ↗ |
| Modality | Other / unclassified | “Microbiome therapeutics LP-51 was applied on the individuals suffering from xerosis” NCT06706050 ↗ |
| Route | Topical | “The products were applied twice daily-morning and evening-to a 3 cm area on both the proximal and distal sides of the designated arm's crook.” NCT06706050 ↗ |